Treatment outcomes of heparin-induced thrombocytopenia in subarachnoid hemorrhage patients: a 4-year, retrospective single-center review.

Neurocritical care 20121001

Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.

The American journal of pathology 20121001

Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful?

American journal of clinical pathology 20121001

Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120915

Translational success stories: development of direct thrombin inhibitors.

Circulation research 20120914

Outcomes after heparin-induced thrombocytopenia in patients with Propaten vascular grafts.

Annals of vascular surgery 20120801

Use of the chromogenic factor X assay in patients transitioning from argatroban to warfarin therapy.

Pharmacotherapy 20120601

In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.

Integrative biology : quantitative biosciences from nano to macro 20120601

Alternative anticoagulation during cardiovascular procedures in pediatric patients with heparin-induced thrombocytopenia.

The journal of extra-corporeal technology 20120601

Thrombin activity associated with neuronal damage during acute focal ischemia.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20120530

Thrombin inhibition profiles in healthy individuals and thrombophilic patients.

Thrombosis and haemostasis 20120501

Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.

The Journal of thoracic and cardiovascular surgery 20120501

Development of a fast and simple liquid chromatography-tandem mass spectrometry method for the quantitation of argatroban in patient plasma samples.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120415

Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - a European Perspective.

Thrombosis research 20120401

Argatroban therapy for heparin-induced thrombocytopenia during pregnancy in a woman with hereditary antithrombin deficiency.

The journal of obstetrics and gynaecology research 20120401

[Anesthesia for a hemodialysis patient with HIT undergoing CABG using argatroban].

Masui. The Japanese journal of anesthesiology 20120401

High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120315

The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study.

Stroke 20120301

The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study.

Stroke 20120301

Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.

Minerva anestesiologica 20120301

Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120201

Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Chest 20120201

Combined argatroban and anti-oxidative agents prevents increased vascular contractility to thrombin and other ligands after subarachnoid haemorrhage.

British journal of pharmacology 20120101

Novel insights into the delayed vasospasm following subarachnoid haemorrhage: importance of proteinase signalling.

British journal of pharmacology 20120101

A case of acute coronary artery occlusion associated with very rapid onset heparin-induced thrombosis without thrombocytopenia.

Internal medicine (Tokyo, Japan) 20120101

Hitting back HIT.

Annals of cardiac anaesthesia 20120101

Hemodialysis with a dialyzer loaded with argatroban may be performed in vivo without a systemic anticoagulant.

Blood purification 20120101

Newer anticoagulants for the prevention of venous thromboembolism.

The National medical journal of India 20120101

Old and new antithrombotic drugs in neonates and infants.

Seminars in fetal & neonatal medicine 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Identifying patient- and treatment-related factors related to amputation risk in cases of heparin-induced thrombocytopenia treated with argatroban.

International angiology : a journal of the International Union of Angiology 20111201

Immobilization of anticoagulant-loaded liposomes on cell surfaces by DNA hybridization.

Biomaterials 20111101

Water-soluble argatroban for antithrombogenic surface coating of tissue-engineered cardiovascular tissues.

Journal of biomedical materials research. Part B, Applied biomaterials 20111101

Systemic administration of argatroban inhibits protease-activated receptor-1 expression in perihematomal tissue in rats with intracerebral hemorrhage.

Brain research bulletin 20111010

Monitoring of the anticoagulants argatroban and lepirudin: a comparison of laboratory methods.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20111001

Direct thrombin inhibitors.

British journal of clinical pharmacology 20111001

Effects of argatroban as an anticoagulant for intermittent veno-venous hemofiltration (IVVH) in patients at high risk of bleeding.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20110901

Heparin-induced thrombocytopenia type II because of heparin-coated polytetrafluoroethylene graft used to bypass.

Annals of vascular surgery 20110801

Management of argatroban surrounding a lumbar puncture: a case report.

American journal of hematology 20110801

Implementation of an individualized argatroban protocol in an academic medical center.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110715

Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study.

Pediatric blood & cancer 20110701

Long-term animal implantation study of biotube-autologous small-caliber vascular graft fabricated by in-body tissue architecture.

Journal of biomedical materials research. Part B, Applied biomaterials 20110701

Profiling of active thrombin in human blood by supramolecular complexes.

Angewandte Chemie (International ed. in English) 20110627

Anticoagulation with argatroban for elective percutaneous coronary intervention: population pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of coagulation parameters.

Journal of clinical pharmacology 20110601

[Diagnosis and treatment of heparin-induced thrombocytopenia].

Deutsche medizinische Wochenschrift (1946) 20110501

Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study.

International journal of cardiology 20110414

Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia.

Seminars in thrombosis and hemostasis 20110401

[Interventional lung assist membrane ventilator. Successful use despite heparin-induced thrombocytopenia type II].

Der Anaesthesist 20110301

Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia.

American journal of hematology 20110301

Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.

The Annals of pharmacotherapy 20110301

Argatroban therapy using enzymatic anti-factor IIa monitoring.

The Annals of pharmacotherapy 20110301

[Efficacy of regional administration of urokinase and argatroban via small saphenous vein catheter for treatment of acute deep venous thrombosis in the lower limb].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20110301

Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT 'overdiagnosis' in a patient with antiphospholipid syndrome.

American journal of hematology 20110201

Thrombosis prophylaxis in critically ill patients.

Wiener medizinische Wochenschrift (1946) 20110201

Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children.

Wiener medizinische Wochenschrift (1946) 20110201

[Synthetic protease inhibitors for the treatment of DIC].

Rinsho byori. The Japanese journal of clinical pathology 20110201

Pharmacokinetic and pharmacodynamic basis for effective argatroban dosing in pediatrics.

Journal of clinical pharmacology 20110101

A patient with 'spontaneous' heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20110101

A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.

American journal of therapeutics 20110101

Hypereosinophilic syndrome with cardiac involvement in a pregnant patient with multiple sclerosis.

Texas Heart Institute journal 20110101

An optimized method to assess in vivo efficacy of antithrombotic drugs using optical coherence tomography and a modified Doppler flow system.

Journal of pharmacological and toxicological methods 20110101

Argatroban 'reversal' is caused by nonphysiologic stimulation of coagulation, not activated factor VII.

Journal of cardiothoracic and vascular anesthesia 20101201

Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in plasma exposed to heparin or argatroban.

Anesthesia and analgesia 20101201

Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.

Pharmacotherapy 20101201

Extracorporeal membrane oxygenation bridging to lung transplant complicated by heparin-induced thrombocytopenia.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20101201

Argatroban administration reduces leukocyte adhesion and improves capillary perfusion within the intestinal microcirculation in experimental sepsis.

Thrombosis and haemostasis 20101101

[Concept of branch atheromatous disease (BAD) and its clinical significance].

Rinsho shinkeigaku = Clinical neurology 20101101

Difficult management of anticoagulation with argatroban in a patient undergoing on-pump cardiac surgery.

Journal of cardiothoracic and vascular anesthesia 20101001

Safety and efficacy of the argatroban therapy during the early post-cardiac surgery period.

Journal of thrombosis and thrombolysis 20101001

Pharmacotherapy in the critically ill obese patient.

Critical care clinics 20101001

Pharmacology of argatroban.

Expert review of hematology 20101001

Low dose of argatroban saline flushes anticoagulation in hemodialysis patients with high risk of bleeding.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20100801

Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: a case report.

Thrombosis research 20100801

Treatment with argatroban in one haemodialysed patient with a heparin-induced thrombocytopenia and thrombotic complications.

Internal and emergency medicine 20100801

Serious acute coronary thrombosis associated with heparin-induced thrombocytopenia in off-pump coronary artery bypass grafting.

Interactive cardiovascular and thoracic surgery 20100801

Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.

Thrombosis and haemostasis 20100801

Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100701

[Heparin-induced thrombocytopenia after on-pump coronary artery bypass grafting].

Kyobu geka. The Japanese journal of thoracic surgery 20100601

An overview of heparin-induced thrombocytopenia.

Journal of pharmacy practice 20100601

The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis.

Thrombosis and haemostasis 20100501

Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis.

Transfusion 20100401

Argatroban as a substitute of heparin during cardiopulmonary bypass: a safe alternative?

Interactive cardiovascular and thoracic surgery 20100401

The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitro.

Thrombosis and haemostasis 20100401

Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.

Clinical therapeutics 20100401

Cooperative antithrombotic effect from the simultaneous inhibition of thrombin and factor Xa.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20100301

Laboratory monitoring of new anticoagulants.

American journal of hematology 20100301

Thrombolytic therapy and thrombectomy in phlegmasia cerulea dolens.

The journal of the Royal College of Physicians of Edinburgh 20100301

Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif.

Journal of medicinal chemistry 20100225

Review: recent advances in argatroban-warfarin transition in patients with heparin-induced thrombocytopenia.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20100201

Heparin-induced thrombocytopenia in two patients undergoing abdominal aortic aneurysm surgery.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20100201

Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db mice.

Endocrinology 20100201

Heparin-induced thrombocytopenia and cardiac surgery.

Current opinion in anaesthesiology 20100201

Simultaneous use of argatroban and heparin during cardiopulmonary bypass.

Asian cardiovascular & thoracic annals 20100201

Impact of renal function on argatroban therapy during percutaneous coronary intervention.

Journal of thrombosis and thrombolysis 20100101

Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia.

International journal of obstetric anesthesia 20100101

An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and activated partial thromboplastin time.

Acta anaesthesiologica Scandinavica 20100101

Autologous small-caliber 'biotube' vascular grafts with argatroban loading: a histomorphological examination after implantation to rabbits.

Journal of biomedical materials research. Part B, Applied biomaterials 20100101

Quantitation of argatroban in plasma using liquid chromatography electrospray tandem mass spectrometry (UPLC-ESI-MS/MS).

Methods in molecular biology (Clifton, N.J.) 20100101

Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.

Critical care (London, England) 20100101

Argatroban in the management of heparin-induced thrombocytopenia.

Vascular health and risk management 20100101

Thrombin inhibition in subarachnoid hemorrhage.

Neurosurgery 20091201

[Heparin-induced thrombocytopenia type II with thrombosis in an intensive care patient: therapy management using the direct thrombin inhibitor argatroban].

Der Anaesthesist 20091101

RapidTEG observation suggests activation of factor VII may overcome argatroban-induced coagulopathy.

Journal of cardiothoracic and vascular anesthesia 20091001

Thrombin generation by intimal tissue factor contributes to thrombus formation on macrophage-rich neointima but not normal intima of hyperlipidemic rabbits.

Atherosclerosis 20091001

Heparin-induced thrombocytopenia with multiple organized thrombi accompanied by unusual cholesterin deposition: autopsy case after long-term follow up.

Pathology international 20091001

[Anticoagulation in critically ill patient].

Wiener medizinische Wochenschrift (1946) 20091001

Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child.

Pediatric blood & cancer 20090901

Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients.

Pharmacotherapy 20090901

[Anesthetic management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].

Masui. The Japanese journal of anesthesiology 20090901

A comparison of direct thrombin inhibitors in the treatment of Heparin-Induced Thrombocytopenia: a single institution experience.

Journal of thrombosis and thrombolysis 20090801

Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20090801

Extremely low doses of lepirudin in a patient with heparin-induced thrombocytopenia, high bleeding risk and renal insufficiency.

British journal of haematology 20090801

HeartMate II implantation in patients with heparin-induced thrombocytopenia type II.

The Annals of thoracic surgery 20090801

Clinical investigation in ACS and PCI: shooting in the dark at a moving target.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20090801

Anterior spinal artery as a collateral channel in patients with acute bilateral vertebral artery occlusions. Two case reports.

Neurologia medico-chirurgica 20090801

Stabilization of the E* form turns thrombin into an anticoagulant.

The Journal of biological chemistry 20090724

Dosing patterns and outcomes in African American, Asian, and Hispanic patients with heparin-induced thrombocytopenia treated with argatroban.

Journal of thrombosis and thrombolysis 20090701

Influence of antithrombin and argatroban on disseminated intravascular coagulation parameters in a patient with septic shock.

Thrombosis research 20090701

INR matters: a case on managing argatroban for bridging oral anticoagulation in a patient with heparin induced thrombocytopenia type II after mechanical heart valve replacement.

Thrombosis research 20090601

Argatroban for anticoagulation in continuous renal replacement therapy.

Critical care medicine 20090601

The effect of argatroban on activated protein C resistance.

American journal of clinical pathology 20090601

Argatroban and bivalirudin compared to unfractionated heparin in preventing thrombus formation on mechanical heart valves. Results of an in-vitro study.

Thrombosis and haemostasis 20090601

Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management.

Chest 20090601

[Clinical observation of heparin-induced thrombocytopenia].

Zhonghua yi xue za zhi 20090526

Thrombin inhibition by argatroban ameliorates early brain injury and improves neurological outcomes after experimental subarachnoid hemorrhage in rats.

Stroke 20090401

Argatroban and catheter-directed thrombolysis with alteplase for limb- and graft-threatening thromboses in a patient with a history of HIT.

American journal of hematology 20090401

[A study of the dosage of argatroban for anticoagulation effect in the patients undergoing high volume hemofiltration].

Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue 20090401

Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation.

Thrombosis and haemostasis 20090301

A report of outcomes after orthotopic liver transplant with allografts from heparin antibody-positive donors.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20090301

[Argatroban treatment of heparin-induced immune-mediated thrombocytopenia].

Ugeskrift for laeger 20090216

[Heparin-induced thrombocytopenia].

Ugeskrift for laeger 20090216

The effect of ex vivo anticoagulants on whole blood platelet aggregation.

Platelets 20090201

84-year-old woman with hemodialysis-associated shortness of breath.

Mayo Clinic proceedings 20090201

Heparin-induced thrombocytopenia: what clinicians need to know.

Thrombosis and haemostasis 20090201

[Use of argatroban during cardiopulmonary bypass for atrial septal defect with heparin induced thrombocytopenia after introduction of dialysis].

Kyobu geka. The Japanese journal of thoracic surgery 20090201

Argatroban for anticoagulation in continuous renal replacement therapy.

Critical care medicine 20090101

'Drug dosing in the intensive care unit: the critically ill are a special population too'.

Critical care medicine 20090101

Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia.

The Annals of pharmacotherapy 20090101

Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.

The Annals of pharmacotherapy 20090101

Argatroban therapy in heparin-induced thrombocytopenia.

AACN advanced critical care 20090101

Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.

Drug safety 20090101

Use of argatroban during multi-organ procurement: pharmacokinetics and sequelae in recipient of transplanted liver.

Clinical transplantation 20090101

Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.

American journal of cardiovascular drugs : drugs, devices, and other interventions 20090101

Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.

Hematology. American Society of Hematology. Education Program 20090101

Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable fibrinolysis inhibitor and factor XIII.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20081201

Successful use of argatroban during the third trimester of pregnancy: case report and review of the literature.

Pharmacotherapy 20081201

Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.

Journal of cardiovascular pharmacology 20081201

Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation.

Blood 20081115

Heparin-induced thrombocytopenia (HIT) causing pulmonary emboli during coronary intervention.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20081115

The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.

Breast cancer research and treatment 20081101

Thrombin enhances the production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 in cultured rat glomerular epithelial cells.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20081101

Use of Argatroban for anticoagulation during cardiopulmonary bypass in a patient with heparin allergy.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20081101

Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20081001

Complete salvage of impending free flap failure in heparin induced thrombocytopenia by emergent institution of therapy with argatroban.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS 20081001

Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.

British journal of haematology 20081001

[Three cases of small brain infarction in the lateral wall of the fourth ventricle presenting with paroxysmal positional vertigo and vomiting].

Rinsho shinkeigaku = Clinical neurology 20081001

Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination.

Bioorganic & medicinal chemistry letters 20080815

Inhibition of osteopontin dependent carcinogenesis.

Journal of cancer research and clinical oncology 20080801

Argatroban use in heparin-induced thrombocytopenia.

Expert opinion on pharmacotherapy 20080801

Therapeutic effect of argatroban on rheumatoid vasculitis with antiphosphatidylserine-prothrombin complex antibody.

Archives of dermatology 20080801

Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Addendum.

Chest 20080801

Influence of continuous veno-venous hemofiltration on argatroban clearance in a patient with septic shock.

Intensive care medicine 20080701

Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20080701

Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effect on coagulation factor testing.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20080701

What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20080701

Interaction between thrombin mutant W215A/E217A and direct thrombin inhibitor.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20080701

Effect of body mass index on Argatroban therapy during percutaneous coronary intervention.

Journal of thrombosis and thrombolysis 20080601

Influence of direct thrombin inhibitor argatroban on coagulation assays in healthy individuals, patients under oral anticoagulation therapy and patients with liver dysfunction.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20080601

Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Chest 20080601

Argatroban in short-term percutaneous ventricular assist subsequent to heparin-induced thrombocytopenia.

The journal of extra-corporeal technology 20080601

Heparins, low-molecular-weight heparins, and pentasaccharides: use in the older patient.

Cardiology clinics 20080501

New anticoagulant agents: direct thrombin inhibitors.

Cardiology clinics 20080501

Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices.

The Annals of thoracic surgery 20080501

Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices. Invited commentary.

The Annals of thoracic surgery 20080501

Bivalirudin.

Thrombosis and haemostasis 20080501

Heparin-induced thrombocytopenia: a review of current pharmacologic treatment.

Connecticut medicine 20080501

Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome.

Journal of thrombosis and thrombolysis 20080401

Argatroban therapy in patients with hepatic and renal impairment.

European journal of anaesthesiology 20080401

[Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20080401

Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.

American journal of hematology 20080301

Reduced argatroban doses after coronary artery bypass graft surgery.

The Annals of pharmacotherapy 20080301

Considerations for drug dosing post coronary artery bypass graft surgery.

The Annals of pharmacotherapy 20080301

Standardizing the management of heparin-induced thrombocytopenia.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080215

The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.

Seminars in thrombosis and hemostasis 20080201

Argatroban therapy in patients with coronary artery disease and heparin-induced thrombocytopenia.

Cardiology 20080101

Visual evaluation of blood coagulation during mural thrombogenesis under high shear blood flow.

Thrombosis research 20080101

Complete 1H and 13C assignments of (21R) and (21S) diastereomers of argatroban.

Magnetic resonance in chemistry : MRC 20080101

Heparin-induced thrombocytopenia complicating hemodialysis.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20080101

Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban.

Anesthesia and analgesia 20080101

[Patient with heparin-induced thrombocytopenia type II and implanted left ventricular assist device].

Der Anaesthesist 20080101

Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.

Thrombosis and haemostasis 20080101

Ultrasound-guided supraclavicular block in a patient anticoagulated with argatroban.

Pain practice : the official journal of World Institute of Pain 20080101

Comparison of the ecarin chromogenic assay and different aPTT assays for the measurement of argatroban concentrations in plasma from healthy individuals and from coagulation factor deficient patients.

Thrombosis research 20080101

Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.

Thrombosis research 20080101

Argatroban anticoagulation in renal dysfunction: a literature analysis.

Nephron. Clinical practice 20080101

Argatroban anticoagulation in intensive care patients: effects of heart failure and multiple organ system failure.

Journal of intensive care medicine 20080101

Argatroban anticoagulation for cardiac surgery with cardiopulmonary bypass in an infant with double outlet right ventricle and a history of heparin-induced thrombocytopenia.

Congenital heart disease 20080101

Treatment of intracardiac thrombi with argatroban.

Acute cardiac care 20080101

Management of a pediatric patient on the Berlin Heart Excor ventricular assist device with argatroban after heparin-induced thrombocytopenia.

ASAIO journal (American Society for Artificial Internal Organs : 1992) 20080101

The use of alternative anti-coagulation strategies for a nocturnal home hemodialysis patient with heparin-induced thrombocytopenia.

CANNT journal = Journal ACITN 20080101

Thrombin enhances glioma growth.

Acta neurochirurgica. Supplement 20080101

Inhibition of thrombin generation in recalcified plasma.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20071201

Catheter-directed thrombolysis of acute lower extremity arterial thrombosis in a patient with heparin-induced thrombocytopenia.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20071201

[Are new anticoagulants better?].

Investigacion clinica 20071201

Development of self-expandable covered stents.

Journal of biomedical materials research. Part B, Applied biomaterials 20071101

Anti-Helicobacter pylori and thrombin inhibitory components from Chinese dragon's blood, Dracaena cochinchinensis.

Journal of natural products 20071001

Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence.

Internal and emergency medicine 20071001

Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20071001

[Heparin-induced thrombocytopenia].

Revista espanola de cardiologia 20071001

A case of heparin-induced thrombocytopenia with repeated episodes of acute lower extremity arterial thromboembolism during a short time.

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20071001

Influence of argatroban on coagulation parameters in heparin-induced thrombocytopenia patients after cardiothoracic surgery.

Journal of thrombosis and haemostasis : JTH 20070901

Heparin induced thrombocytopenia: diagnosis and management update.

Postgraduate medical journal 20070901

Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.

Current cardiology reports 20070901

Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects.

Cardiovascular & hematological disorders drug targets 20070901

Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.

Journal of clinical pharmacology 20070801

Heparin-induced thrombocytopenia II-induced critical limb ischaemia treated with urokinase and argatroban.

Thrombosis and haemostasis 20070801

Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury.

Experimental neurology 20070701

Argatroban in extracorporeal membrane oxygenation.

Artificial organs 20070601

Efficacy of anti-coagulant treatment with argatroban on cardioembolic stroke.

Journal of neurology 20070501

Argatroban anticoagulation in critically ill patients.

The Annals of pharmacotherapy 20070501

Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery.

The Journal of thoracic and cardiovascular surgery 20070501

Heparin-induced thrombocytopenia and thrombosis.

American journal of orthopedics (Belle Mead, N.J.) 20070501

Assessing nonlinearity in compartment models via the relative curvature measure.

Journal of pharmacokinetics and pharmacodynamics 20070401

Heparin-induced thrombocytopenia in intensive care patients.

Critical care medicine 20070401

Heparin-induced thrombocytopenia: treatment options and special considerations.

Pharmacotherapy 20070401

Impact of smart infusion technology on administration of anticoagulants (unfractionated Heparin, Argatroban, Lepirudin, and Bivalirudin).

The American journal of cardiology 20070401

Essentials of anticoagulation in hemodialysis.

Hemodialysis international. International Symposium on Home Hemodialysis 20070401

Argatroban for anticoagulation in pediatric patients with heparin-induced thrombocytopenia requiring extracorporeal life support.

Journal of pediatric hematology/oncology 20070401

Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20070301

Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin.

Arteriosclerosis, thrombosis, and vascular biology 20070201

[Two surgical case reports showing atypical heparin-induced thrombocytopenia].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20070201

Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.

Journal of cardiothoracic and vascular anesthesia 20070201

[Bilateral cerebellar infarction caused by intracranial dissection of the vertebral artery after long periods of 'Shiatsu'].

No to shinkei = Brain and nerve 20070201

Argatroban for anticoagulation during cardiac surgery.

European journal of haematology 20070201

Hydroxyethyl starch enhances argatroban-mediated decreases in clot propagation and strength by diminishing thrombin-fibrinogen interactions.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20070101

Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.

Expert review of cardiovascular therapy 20070101

Anticoagulation options for patients with heparin-induced thrombocytopenia requiring renal support in the intensive care unit.

Contributions to nephrology 20070101

Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.

Drugs & aging 20070101

Heparin-induced thrombocytopenia: a general review.

Journal of infusion nursing : the official publication of the Infusion Nurses Society 20070101

A case series describing the use of argatroban in patients on extracorporeal circulation.

ASAIO journal (American Society for Artificial Internal Organs : 1992) 20070101

Argatroban therapy in women with heparin-induced thrombocytopenia.

Journal of women's health (2002) 20070101

Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.

Reviews in cardiovascular medicine 20070101

Direct thrombin inhibitors: alternatives to heparin.

Vascular 20070101

Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.

Critical care medicine 20061201

Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.

Journal of thrombosis and thrombolysis 20061201

Heparin-induced thrombocytopenia: advances in diagnosis and treatment.

Critical care nurse 20061201

Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.

Pharmacotherapy 20061201

Heparin-induced thrombocytopenia without thrombosis: an evidence-based review of current literature.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 20061201

[Argatroban].

Nihon rinsho. Japanese journal of clinical medicine 20061028

Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature.

Pharmacotherapy 20061001

Systemic anticoagulation with argatroban during arteriovenous dialysis graft thrombolysis.

Journal of vascular and interventional radiology : JVIR 20061001

Flavonoids inhibit the amidolytic activity of human thrombin.

Biochimie 20060901

Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: first results from the ARG-E03 trial.

The Journal of thoracic and cardiovascular surgery 20060901

Argatroban tPA stroke study: study design and results in the first treated cohort.

Archives of neurology 20060801

[Two cases of heparin-induced thrombocytopenia (HIT) and a review of the literature].

[Rinsho ketsueki] The Japanese journal of clinical hematology 20060801

On-chip titration of an anticoagulant argatroban and determination of the clotting time within whole blood or plasma using a plug-based microfluidic system.

Analytical chemistry 20060715

Heparin-induced thrombocytopenia and cardiovascular diseases.

American heart journal 20060701

Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20060601

Recognition and management of heparin-induced thrombocytopenia in pediatric cardiopulmonary bypass patients.

The Annals of thoracic surgery 20060601

Thrombotic end point for assessing argatroban therapy for heparin-induced thrombocytopenia: learning from secondary analyses of prospective studies.

Chest 20060601

Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia.

Chest 20060601

Argatroban: update.

American heart journal 20060601

[Pharmacotherapy: argatroban--alternative to heparin in case of heparin-induced thrombocytopenia type II (HIT II)].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20060601

[Advanced medical therapy in patients with acute ischemic stroke].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20060601

Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal support and treated with argatroban.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 20060501

Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome.

The Annals of pharmacotherapy 20060501

Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.

Chest 20060501

Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organotypic slice cultures.

Neurobiology of disease 20060401

[Argatroban: pharmacological properties and anaesthesiological aspects].

Der Anaesthesist 20060401

Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.

Pharmacotherapy 20060401

Inhibitors of blood coagulation factors Xa and IIa synergize to reduce thrombus weight and thrombin generation in vivo and in vitro.

Journal of thrombosis and haemostasis : JTH 20060401

Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actions.

Drugs of today (Barcelona, Spain : 1998) 20060401

Cardiac surgery in a patient with heparin-induced thrombocytopenia--cautions with use of the direct thrombin inhibitor, argatroban.

Connecticut medicine 20060401

[Argatroban].

Deutsche medizinische Wochenschrift (1946) 20060331

Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.

Current hematology reports 20060301

A new method for assessment of an anti-5HT(2A) agent, sarpogrelate hydrochloride, on platelet aggregation.

Journal of thrombosis and haemostasis : JTH 20060201

Treatment of heparin-induced thrombocytopenia in cardiovascular patients.

Expert opinion on pharmacotherapy 20060201

Successful recovery after an overdose of argatroban.

The Annals of pharmacotherapy 20060201

[A case of heparin-induced thrombocytopenia associated with unexpected excessive argatroban anticoagulation after abdominal aortic aneurysm resection].

Masui. The Japanese journal of anesthesiology 20060201

Antithrombin reduces reperfusion-induced hepatic metastasis of colon cancer cells.

World journal of gastroenterology 20060107

Argatroban, a direct thrombin inhibitor for heparin-induced thrombocytopaenia: present and future perspectives.

Expert opinion on pharmacotherapy 20060101

The cost-effectiveness of argatroban treatment in heparin-induced thrombocytopenia: the effect of early versus delayed treatment.

Cardiology in review 20060101

Argatroban anticoagulation in pediatric patients: a literature analysis.

Journal of pediatric hematology/oncology 20060101

Heparin-induced thrombocytopenia and cardiovascular patients: recognition and treatment.

Progress in cardiovascular nursing 20060101

Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital.

Journal of intensive care medicine 20060101

When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients.

Seminars in dialysis 20060101

Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.

Renal failure 20060101

Treatment of heparin-induced thrombocytopenia: a practical argatroban dosing protocol for nurses.

Journal of infusion nursing : the official publication of the Infusion Nurses Society 20060101

3,6-disubstituted coumarins as mechanism-based inhibitors of thrombin and factor Xa.

Journal of medicinal chemistry 20051201

Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.

Pharmacotherapy 20051201

Heparin-induced thrombocytopenia from venous thromboembolism treatment.

Journal of internal medicine 20051201

Comment: extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer.

The Annals of pharmacotherapy 20051101

Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.

Thrombosis and haemostasis 20051101

Mechanism of antithrombotic effect of heparin and antithrombin in balloon-injured arteries.

Life sciences 20051007

Argatroban-coupled Affi-Gel matrix for the purification of thrombin from plasma.

Biotechnology and applied biochemistry 20051001

Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.

The Annals of pharmacotherapy 20051001

Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing.

American journal of clinical pathology 20051001

Argatroban and lepirudin requirements in a 6-year-old patient with heparin-induced thrombocytopenia.

Pharmacotherapy 20051001

Argatroban and lepirudin: clinical trials to clinical practice.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20051001

A comparison of lepirudin and argatroban outcomes.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20051001

[A case of anterior cerebral artery dissection causing enlargement of infarction].

Rinsho shinkeigaku = Clinical neurology 20051001

Direct thrombin inhibitors.

The New England journal of medicine 20050908

The role of thrombin in gliomas.

Journal of thrombosis and haemostasis : JTH 20050901

Collaborative study on monitoring methods to determine direct thrombin inhibitors lepirudin and argatroban.

Journal of thrombosis and haemostasis : JTH 20050901

Acute subdural hematoma: new model delineation and effects of coagulation inhibitors.

Neurosurgery 20050901

Heparin and other rapidly acting anticoagulants.

Seminars in vascular surgery 20050901

Cardiopulmonary bypass using argatroban as an anticoagulant for a 6.0-kg pediatric patient.

The journal of extra-corporeal technology 20050901

Successful therapy with argatroban for superior mesenteric vein thrombosis in a patient with congenital antithrombin deficiency.

European journal of haematology 20050801

New antithrombotics in the prevention of thromboembolic disease.

European journal of internal medicine 20050801

Scanning electron microscopical observations of two novel hemostatic polymers.

Journal of thrombosis and haemostasis : JTH 20050701

Thrombin inhibitor reduces leukocyte-endothelial cell interactions and vascular leakage after scatter laser photocoagulation.

Investigative ophthalmology & visual science 20050701

Toxicity of argatroban overdose in a 65-year-old man.

American journal of hematology 20050701

Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20050701

[Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].

Rinsho byori. The Japanese journal of clinical pathology 20050701

Evolving management strategies for heparin-induced thrombocytopenia.

Seminars in hematology 20050701

Effect of argatroban on the activated partial thromboplastin time: a comparison of 21 commercial reagents.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20050601

Extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer.

The Annals of pharmacotherapy 20050601

Direct thrombin inhibitors: pharmacology and clinical relevance.

Anaesthesia 20050601

[Nontraumatic arterial dissection of the anterior cerebral artery: six cases report].

No to shinkei = Brain and nerve 20050601

Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).

Journal of thrombosis and thrombolysis 20050601

The paradox of heparin-induced thrombocytopenia: the initial management.

Orthopedics 20050601

Carotid tissue levels of argatroban after direct local delivery during carotid endarterectomy to prevent perioperative cerebral embolism.

Neurosurgery 20050501

No increase in rejection or graft loss in kidney transplant recipients with thrombophilia treated with anticoagulation and triple immunosuppression.

Transplantation proceedings 20050501

The use of argatroban for carotid endarterectomy in heparin-induced thrombocytopenia.

Anesthesia and analgesia 20050401

Argatroban for anticoagulation during cardiopulmonary bypass in an infant.

Paediatric anaesthesia 20050401

An anesthesia provider's perspective of heparin-induced thrombocytopenia.

AANA journal 20050401

Heparin-induced thrombocytopenia: principles for early recognition and management.

Cleveland Clinic journal of medicine 20050401

In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.

Journal of medicinal chemistry 20050324

Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models.

Thrombosis and haemostasis 20050301

Coagulation management of a patient with factor V Leiden mutation, lupus anticoagulant, and activated protein C resistance: a case report.

Perfusion 20050301

Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.

The Annals of pharmacotherapy 20050201

Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.

Chest 20050201

Direct thrombin inhibitors in heparin-induced thrombocytopenia.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050201

Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarin.

Pharmacotherapy 20050201

Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.

Journal of thrombosis and thrombolysis 20050201

Spontaneous atrioventricular groove disruption during off-pump coronary artery bypass grafting.

The Annals of thoracic surgery 20050101

Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20050101

Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.

American heart journal 20050101

Thrombin-directed inhibitors: pharmacology and clinical use.

American heart journal 20050101

Systemic administration of argatroban reduces secondary brain damage in a rat model of intracerebral hemorrhage: histopathological assessment.

Cerebrovascular diseases (Basel, Switzerland) 20050101

Argatroban treatment for patients with intolerance to heparin and hirudin.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20050101

Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor.

Expert review of cardiovascular therapy 20050101

Selective methodologies for the synthesis of biologically active piperidinic compounds.

Chemical record (New York, N.Y.) 20050101

Heparin-induced thrombocytopenia.

Disease-a-month : DM 20050101

Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.

Thrombosis research 20050101

Clinical presentation and laboratory diagnosis of heparin-induced thrombocytopenia.

Seminars in thoracic and cardiovascular surgery 20050101

Anticoagulant use in patients with chronic renal impairment.

American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101

Direct thrombin inhibitors are not equally effective in vivo against arterial thrombosis: in vivo evaluation of DuP714 and argatroban in a porcine angioplasty model and comparison to r-hirudin.

Thrombosis research 20050101

New trends in anticoagulant treatments.

Lupus 20050101

Thrombocytopenia following heparin flush.

Progress in cardiovascular nursing 20050101

Inhibition of thrombin-induced vascular endothelial growth factor production in human neuroblastoma (NB-1) cells by argatroban.

Pathophysiology of haemostasis and thrombosis 20050101

Direct thrombin inhibitors for treatment of heparin induced thrombocytopenia, deep vein thrombosis and atrial fibrillation.

Current pharmaceutical design 20050101

Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models.

Acta neurochirurgica. Supplement 20050101

Severe argatroban-induced coagulopathy in a patient with a history of heparin-induced thrombocytopenia.

The Annals of thoracic surgery 20041201

Argatroban as a heparin substitute in cases of heparin-induced thrombocytopenia.

The Annals of thoracic surgery 20041201

A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease.

Kidney international 20041201

Current role of antithrombotic agents in the treatment of acute coronary syndromes.

Seminars in thrombosis and hemostasis 20041201

Compatibility of argatroban with selected cardiovascular agents.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041115

[Clinical guidelines for stroke].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20041110

Heparin-induced thrombocytopenia: diagnosis and management.

Circulation 20041102

The effects of argatroban on thrombin generation and hemostatic activation in vitro.

Anesthesia and analgesia 20041101

Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing.

Archives of pathology & laboratory medicine 20041001

Monitoring direct thrombin inhibitors: time for standardization.

Anesthesiology 20041001

Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.

The Annals of pharmacotherapy 20040901

Pharmacokinetics and pharmacodynamics of argatroban in combination with a platelet glycoprotein IIB/IIIA receptor antagonist in patients undergoing percutaneous coronary intervention.

Journal of clinical pharmacology 20040901

[Use of argatroban as a substitute for heparin in a patient with suspected HIT type II undergoing carotid endarterectomy].

Masui. The Japanese journal of anesthesiology 20040901

[Prospective randomized study of argatroban versus heparin anticoagulation therapy after percutaneous coronary intervention for acute myocardial infarction].

Journal of cardiology 20040801

Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: an open-label, nonrandomized pilot study.

Journal of thrombosis and thrombolysis 20040801

[Prevention and treatment of deep vein thrombosis with ximelagatran].

Deutsche medizinische Wochenschrift (1946) 20040723

Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions.

Journal of the American College of Cardiology 20040721

Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study.

Stroke 20040701

Intraoperative management of a congenital antithrombin deficient patient on chronic hemodialysis.

Thrombosis and haemostasis 20040701

Local delivery of argatroban for the prevention of restenosis after coronary balloon angioplasty: a prospective randomized pilot study.

Circulation journal : official journal of the Japanese Circulation Society 20040701

Heparin-induced thrombocytopenia and thrombosis in a patient with polycythemia vera.

Internal medicine (Tokyo, Japan) 20040701

Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting Time.

Thrombosis and haemostasis 20040601

Collagen-induced generation of platelet-derived microparticles in whole blood is dependent on ADP released from red blood cells and calcium ions.

Platelets 20040601

[Heparin-induced thrombocytopenia in patients on hemodialysis].

Nihon rinsho. Japanese journal of clinical medicine 20040601

Direct thrombin inhibitors in the treatment of immune-mediated heparin-induced thrombocytopenia.

Seminars in thrombosis and hemostasis 20040601

Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia.

Seminars in thrombosis and hemostasis 20040601

Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia.

The journal of extra-corporeal technology 20040601

Heparinless cardiopulmonary bypass with argatroban in dogs.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20040501

Argatroban therapy for antithrombin deficiency and mesenteric thrombosis: case report and review of the literature.

Pharmacotherapy 20040501

[How to use anticoagulants in hemodialysis therapy].

Nihon rinsho. Japanese journal of clinical medicine 20040501

[Anticoagulant].

Nihon rinsho. Japanese journal of clinical medicine 20040501

Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy.

Critical care medicine 20040401

Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values.

American journal of clinical pathology 20040401

Synthetic selective inhibitors of coagulation factor Xa strongly inhibit thrombin generation without affecting initial thrombin forming time necessary for platelet activation in hemostasis.

Journal of thrombosis and haemostasis : JTH 20040401

Acute ischemic stroke successfully treated using sequenced intravenous and intra-arterial thrombolysis and argatroban anticoagulation: a case study.

Journal of thrombosis and thrombolysis 20040401

Developing an algorithm for treating heparin-induced thrombocytopenia.

Clinical advances in hematology & oncology : H&O 20040401

Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban.

The Journal of pharmacology and experimental therapeutics 20040301

Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction.

Pharmacotherapy 20040301

Small-molecule direct antithrombins: argatroban.

Best practice & research. Clinical haematology 20040301

Treatment of heparin-induced thrombocytopenia: a critical review.

Archives of internal medicine 20040223

Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII.

Anesthesiology 20040201

Failure of argatroban anticoagulation during off-pump coronary artery bypass surgery.

The Annals of thoracic surgery 20040201

Argatroban use during pediatric interventional cardiac catheterization.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20040101

Influence of conduction disturbances on clinical outcome in patients with acute myocardial infarction receiving thrombolysis (results from the ARGAMI-2 study).

The American journal of cardiology 20040101

Argatroban use in dialysis patients.

Seminars in dialysis 20040101

Effect of renal function on the pharmacodynamics of argatroban.

The Annals of pharmacotherapy 20040101

Direct thrombin inhibitors.

Clinical laboratory science : journal of the American Society for Medical Technology 20040101

Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits.

Perfusion 20040101

Thrombin inhibitor, argatroban, prevents tumor cell migration and bone metastasis.

Oncology 20040101

Alternatives to heparin infusion.

Journal of infusion nursing : the official publication of the Infusion Nurses Society 20040101

Argatroban, a new treatment option for heparin-induced thrombocytopenia.

Critical care nurse 20031201

Predictive value of serial platelet count and VEGF determination for the management of DIC in the Crow-Fukase (POEMS) syndrome.

Internal medicine (Tokyo, Japan) 20031201

Treatment options for heparin-induced thrombocytopenia.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031015

Direct thrombin inhibitor therapy in the cardiovascular patient.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031015

Argatroban for off-pump coronary artery bypass surgery.

Anesthesia and analgesia 20031001

Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?

American heart journal 20031001

Vascular surgery using argatroban in a patient with a history of heparin-induced thrombocytopenia.

Circulation journal : official journal of the Japanese Circulation Society 20031001

Differential effects of DX-9065a, argatroban, and synthetic pentasaccharide on tissue thromboplastin inhibition test and dilute Russell's viper venom test.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20031001

Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.

The Annals of pharmacotherapy 20030901

Decreased argatroban clearance unaffected by hemodialysis in anasarca.

The Annals of pharmacotherapy 20030901

Antithrombotic properties of a direct thrombin inhibitor with a prolonged half-life and AT-mediated factor Xa inhibitory activity.

Journal of thrombosis and haemostasis : JTH 20030901

Argatroban inhibits staphylothrombin.

Journal of thrombosis and haemostasis : JTH 20030901

Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide.

Journal of medicinal chemistry 20030814

Argatroban attenuates leukocyte- and platelet-endothelial cell interactions after transient retinal ischemia.

Stroke 20030801

Effects of argatroban as an anticoagulant for haemodialysis in patients with antithrombin III deficiency.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030801

Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.

Archives of internal medicine 20030801

Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.

The Journal of thoracic and cardiovascular surgery 20030801

Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig.

European journal of pharmacology 20030725

Obstinate thrombosis during percutaneous coronary intervention in a case with heparin-induced thrombocytopenia with thrombosis syndrome successfully treated by argatroban anticoagulant therapy.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20030701

Direct thrombin inhibitors during PCI.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20030701

Heparin-induced thrombocytopenia--recognition and treatment.

AORN journal 20030701

Ecarin chromogenic assay--a new method for quantitative determination of direct thrombin inhibitors like hirudin.

Pathophysiology of haemostasis and thrombosis 20030701

The thrombin inhibitor argatroban does not influence the endothelium-dependent relaxant and contractile responses of isolated rabbit carotid arteries.

Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20030601

Excessive argatroban anticoagulation for heparin-induced thrombocytopenia.

The Annals of pharmacotherapy 20030501

Suppression of argatroban-induced endogenous thrombolysis by PKSI-527, and antibodies to TPA and UPA, evaluated in a rat arterial thrombolysis model.

Thrombosis and haemostasis 20030501

Successful use of Argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient.

The Annals of thoracic surgery 20030501

Direct thrombin inhibitors.

Expert opinion on pharmacotherapy 20030501

Predicting the pharmacology of thrombin inhibitors.

Journal of thrombosis and haemostasis : JTH 20030501

Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.

Thrombosis research 20030501

Hemostatic analysis of a patient undergoing off-pump coronary artery bypass surgery with argatroban anticoagulation.

Anesthesia and analgesia 20030401

Anticoagulation in acute cardiac care in patients with chronic kidney disease.

American heart journal 20030401

Argatroban as an alternative anticoagulant for patients with heparin allergy during coronary bypass surgery.

Heart and vessels 20030301

Argatroban, specific thrombin inhibitor, induced phenotype change of cultured rabbit vascular smooth muscle cells.

European journal of pharmacology 20030207

Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use.

The Annals of thoracic surgery 20030201

Characteristics of the hemostatic action of KFA-1411, an inhibitor of coagulation factor Xa (FXa), in humans and various animals.

The Journal of toxicological sciences 20030201

Clinician update: direct thrombin inhibitors in acute coronary syndromes.

Journal of thrombosis and thrombolysis 20030201

Acute pulmonary thromboembolism induced by prophylactic heparin use and a heparin-coated catheter: a case of heparin-induced thrombocytopenia and thrombosis syndrome.

Circulation journal : official journal of the Japanese Circulation Society 20030101

Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia.

Seminars in dialysis 20030101

Direct thrombin inhibitors in cardiac disease.

Cardiovascular toxicology 20030101

Effects of argatroban and heparin on thrombus formation and tissue plasminogen activator-induced thrombolysis in a microvascular thrombosis model.

Thrombosis research 20030101

Argatroban dosing in patients with heparin-induced thrombocytopenia.

The Annals of pharmacotherapy 20030101

Mild hypothermia enhances the neuroprotective effects of a selective thrombin inhibitor following transient focal ischemia in rats.

Acta neurochirurgica. Supplement 20030101

Effect of delayed argatroban treatment on intracerebral hemorrhage-induced edema in the rat.

Acta neurochirurgica. Supplement 20030101

A thrombin inhibitor reduces brain edema, glioma mass and neurological deficits in a rat glioma model.

Acta neurochirurgica. Supplement 20030101

The effect of dietary bacillus natto productive protein on in vivo endogenous thrombolysis.

Pathophysiology of haemostasis and thrombosis 20030101

Studies on the different modes of action of the anticoagulant protease inhibitors DX-9065a and Argatroban. II. Effects on fibrinolysis.

The Journal of biological chemistry 20021227

Studies on the different modes of action of the anticoagulant protease inhibitors DX-9065a and Argatroban. I. Effects on thrombin generation.

The Journal of biological chemistry 20021227

Thrombosis increases circulatory hepatocyte growth factor by degranulation of mast cells.

Circulation 20021210

Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage.

Stroke 20021201

Argatroban in adult extracorporeal membrane oxygenation.

The journal of extra-corporeal technology 20021201

Lack of pharmacokinetic interactions between argatroban and warfarin.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20021101

Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome.

The American journal of the medical sciences 20021101

Influence of lepirudin, argatroban, and melagatran on prothrombin time and additional effect of oral anticoagulation.

Clinical chemistry 20021001

Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20021001

Argatroban for percutaneous coronary interventions: hit or miss?

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20021001

Hirudin in heparin-induced thrombocytopenia.

Seminars in thrombosis and hemostasis 20021001

Visual compatibility of argatroban with selected drugs.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020915

Current agents for the treatment of patients with heparin-induced thrombocytopenia.

Current opinion in pulmonary medicine 20020901

Comment: treatment of heparin-induced thrombocytopenia.

The Annals of pharmacotherapy 20020901

Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia.

American journal of hematology 20020901

Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes.

Postgraduate medicine 20020901

Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.

Current opinion in investigational drugs (London, England : 2000) 20020801

[Experimental and clinical results with the thrombin inhibitor Argatroban].

Hamostaseologie 20020801

Monitoring of anticoagulant effects of direct thrombin inhibitors.

Seminars in thrombosis and hemostasis 20020801

Investigation of the interaction between argatroban and acetaminophen, lidocaine, or digoxin.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020701

Monitoring of argatroban in ARG310 study: potential recommendations for its use in interventional cardiology.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20020701

Direct antithrombin agents ameliorate disseminated intravascular coagulation in suspected heparin-induced thrombocytopenia thrombosis syndrome.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20020701

The role of thrombin inhibition during percutaneous coronary intervention.

Pharmacotherapy 20020601

[Heparin-induced thrombocytopenia: the clinical picture and treatment].

[Rinsho ketsueki] The Japanese journal of clinical hematology 20020601

Anticoagulant therapy with a selective thrombin inhibitor for acute cerebral infarction: usefulness of coagulation markers for evaluation of efficacy.

Journal of thrombosis and thrombolysis 20020601

Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils.

Neuroscience research 20020501

Long-term inhibition of nitric oxide synthesis increases arterial thrombogenecity in rat carotid artery.

American journal of physiology. Heart and circulatory physiology 20020401

Direct thrombin inhibitors for percutaneous coronary intervention in the current era of platelet glycoprotein IIb/IIIa inhibition.

Journal of interventional cardiology 20020401

Treatment of heparin-induced thrombocytopenia.

The Annals of pharmacotherapy 20020301

Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia.

Thrombosis research 20020301

Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice.

Journal of cardiovascular pharmacology 20020201

Platelet shape changes and adhesion under high shear flow.

Arteriosclerosis, thrombosis, and vascular biology 20020201

Substitution of Gly-548 to Ala in the substrate binding pocket of prothrombin Perijá leads to the loss of thrombin proteolytic activity.

Thrombosis and haemostasis 20020201

An antibody that binds to primary specific pocket-associated structure in the active site of bovine thrombin.

Hybridoma and hybridomics 20020201

Argatroban.

Journal of thrombosis and thrombolysis 20020201

Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.

Lancet (London, England) 20020126

Thrombin active site inhibitors: chemical synthesis, in vitro and in vivo pharmacological profile of a novel and selective agent BMS-189090 and analogues.

Bioorganic & medicinal chemistry letters 20020107

Molecular design and structure--activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664.

Bioorganic & medicinal chemistry letters 20020107

[Intraoperative management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].

Masui. The Japanese journal of anesthesiology 20020101

Enhancement of endogenous plasminogen activator-induced thrombolysis by argatroban and APC and its control by TAFI, measured in an arterial thrombolysis model in vivo using rat mesenteric arterioles.

Thrombosis and haemostasis 20020101

Therapeutic considerations in the management of patients with heparin-induced thrombocytopenia.

Progress in cardiovascular nursing 20020101

Role of thrombin in CNS damage associated with intracerebral haemorrhage: opportunity for pharmacological intervention?

CNS drugs 20020101

Effect of phenprocoumon on monitoring of lepirudin, argatroban, melagatran and unfractionated heparin with the PiCT method.